de Kraker MEA - Search Results

1

Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.

Hassoun-Kheir N, Hussein K, Karram M, Saffuri M, Badaan S, Peleg S, de Kraker MEA, Aboelhega W, Warman S, Alon T, Eluk O, Geffen Y, Paul M. Hassoun-Kheir N, et al. Among authors: de kraker mea. Clin Microbiol Infect. 2023 May;29(5):629-634. doi: 10.1016/j.cmi.2023.01.005. Epub 2023 Jan 12. Clin Microbiol Infect. 2023. PMID: 36641053 Free article.

2

Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011.

Dautzenberg MJ, Ossewaarde JM, de Kraker ME, van der Zee A, van Burgh S, de Greeff SC, Bijlmer HA, Grundmann H, Cohen Stuart JW, Fluit AC, Troelstra A, Bonten MJ. Dautzenberg MJ, et al. Euro Surveill. 2014 Mar 6;19(9):20723. doi: 10.2807/1560-7917.es2014.19.9.20723. Euro Surveill. 2014. PMID: 24626209 Free article.

3

Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries.

Borg MA, de Kraker M, Scicluna E, van de Sande-Bruinsma N, Tiemersma E, Monen J, Grundmann H; ARMed Project Members and Collaborators. Borg MA, et al. J Antimicrob Chemother. 2007 Dec;60(6):1310-5. doi: 10.1093/jac/dkm365. Epub 2007 Oct 2. J Antimicrob Chemother. 2007. PMID: 17913724

4

Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.

de Kraker ME, Stolk WA, van Oortmarssen GJ, Habbema JD. de Kraker ME, et al. Trop Med Int Health. 2006 May;11(5):718-28. doi: 10.1111/j.1365-3156.2006.01606.x. Trop Med Int Health. 2006. PMID: 16640625 Free article. Review.

5

Wiping Is Inferior to Rubbing: A Note of Caution for Hand Hygiene With Alcohol-Based Solutions.

Ory J, Zingg W, de Kraker MEA, Soule H, Pittet D. Ory J, et al. Among authors: de kraker mea. Infect Control Hosp Epidemiol. 2018 Mar;39(3):332-335. doi: 10.1017/ice.2017.307. Epub 2018 Jan 30. Infect Control Hosp Epidemiol. 2018. PMID: 29378674

6

Burden of Antimicrobial Resistance: Compared to What?

de Kraker MEA, Lipsitch M. de Kraker MEA, et al. Epidemiol Rev. 2022 Jan 14;43(1):53-64. doi: 10.1093/epirev/mxab001. Epidemiol Rev. 2022. PMID: 33710259 Free PMC article.

7

Antibiotic resistance in the southeastern Mediterranean--preliminary results from the ARMed project.

Borg MA, Scicluna E, de Kraker M, van de Sande-Bruinsma N, Tiemersma E, Gür D, Ben Redjeb S, Rasslan O, Elnassar Z, Benbachir M, Pieridou Bagatzouni D, Rahal K, Daoud Z, Grundmann H, Monen J. Borg MA, et al. Euro Surveill. 2006 Jul;11(7):164-7. Euro Surveill. 2006. PMID: 16966796

8

Clinical impact of antimicrobial resistance: design matters.

Grundmann H, de Kraker M, Davey P. Grundmann H, et al. Lancet Infect Dis. 2011 May;11(5):344; author reply 344-5. doi: 10.1016/S1473-3099(11)70107-4. Lancet Infect Dis. 2011. PMID: 21530889 No abstract available.

9

Health and economic impacts of antibiotic resistance in European hospitals--outlook on the BURDEN project.

Kaier K, Wilson C, Chalkley M, Davey PG, Suetens C, Grundmann H, de Kraker M, Schumacher M, Wolkewitz M, Frank U. Kaier K, et al. Infection. 2008 Oct;36(5):492-4. doi: 10.1007/s15010-008-7453-0. Epub 2008 Sep 13. Infection. 2008. PMID: 18791837 No abstract available.

10

Trends in antimicrobial resistance in Europe: update of EARSS results.

de Kraker M, van de Sande-Bruinsma N. de Kraker M, et al. Euro Surveill. 2007 Mar 15;12(3):E070315.3. doi: 10.2807/esw.12.11.03156-en. Euro Surveill. 2007. PMID: 17439787 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters